Cargando…

Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study

BACKGROUND: To investigate vascular-related pathophysiological characteristics of two human lung cancers with modifiable vascularisation using MRI and CT. METHODS: Tumour xenografts with modifiable vascularisation were established in 71 rats (approval by the Animal Care Committee was obtained) by su...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirus, M., Tokalov, S. V., Wolf, G., Heinold, J., Prochnow, V., Abolmaali, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909347/
https://www.ncbi.nlm.nih.gov/pubmed/29708186
http://dx.doi.org/10.1186/s41747-017-0014-5
Descripción
Sumario:BACKGROUND: To investigate vascular-related pathophysiological characteristics of two human lung cancers with modifiable vascularisation using MRI and CT. METHODS: Tumour xenografts with modifiable vascularisation were established in 71 rats (approval by the Animal Care Committee was obtained) by subcutaneous transplantation of two human non-small-cell lung cancer (NSCLC) cells (A549, H1299) either alone or co-transplanted with vascular growth promoters. The vascularity of the tumours was assessed noninvasively by MRI diffusion-weighted-imaging (DWI), T2-weighted, and time-of-flight (TOF) sequences) as well as contrast-enhanced CT (CE-CT), using clinical scanners. As a reference standard, histological examinations (CD-31, fluorescent beads) were done after explantation. RESULTS: Microvessel density (MVD) was higher in co-transplanted tumours (171 ± 19 number/mm(2)) than in non-co-transplanted tumours (111 ± 11 number/mm(2); p = 0.002). Co-transplanted tumours showed higher growth rates and larger tumour vessels at TOF-MRI as well as larger necrotic areas at CE-CT. In co-transplanted tumours, DWI revealed higher cellularity (lower minimal ADC(diff) 166 ± 15 versus 346 ± 27 mm(2)/s × 10(−6); p < 0.001), highly necrotic areas (higher maximal ADC(diff) 1695 ± 65 versus 1320 ± 59 mm(2)/s × 10(−6); p < 0.001), and better-perfused tumour stroma (higher ADC(perf) 723 ± 36 versus 636 ± 51 mm(2)/s × 10(−6); p = 0.005). Significant correlations were found using qualitative and quantitative parameters: maximal ADC(perf) and MVD (r = 0.326); maximal ADC(diff) and relative necrotic volume on CE-CT (r = 0.551); minimal ADC(diff) and MVD (r = −0.395). CONCLUSIONS: Pathophysiological differences related to vascular supply in two human lung cancer cell lines with modifiable vascularity are quantifiable with clinical imaging techniques. Imaging parameters of vascularisation correlated with the results of histology. DWI was able to characterise both the extent of necrosis and the level of perfusion.